Relationship of Helicobacter pylori CagA status to gastric cell proliferation and apoptosis

Digestive Diseases and Sciences

Volumn 44, Issue 3, 1999, Pages 487-493

  Rokkas, Theodore ^a,b,c   Ladas, Spiros ^a,b   Liatsos, Christos ^a,b   Petridou, Evangelia ^a,b   Papatheodorou, George ^a,b   Theocharis, Stamatis ^a,b   Karameris, Andreas ^a,b   Raptis, Sotirios ^a,b  

^a 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Apoptosis; CagA Status; Gastric carcinogenesis; Helicobacter pylori infection; Proliferation

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER RISK; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HUMAN; INFLAMMATORY INFILTRATE; MALE; PRIORITY JOURNAL; SILVER STAINING; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS;

EID: 0032987485     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026636803101     Document Type: Article

References (54)

1. 1. Marshall BJ, McGechie DB, Rogers PA, Glancy RJ: Pyloric Campylobacter infection and gastroduodenal disease. Med J Aust 142:439-444, 1985
2. 2. Rokkas T, Sladen G: Infection with Campylobacter pylori. J R Coll Phys London 22:97-100, 1988
3. 3. Graham D: Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615-625, 1989
4. 4. Raws EA, Tytgat GNJ: Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 335:1233-1235, 1990
5. 5. Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T: The role of infectious agents in peptic ulcer disease. Gastroenterol Int 6:76-89, 1993
6. 6. Sipponen P, Kosunen TU, Valle J, Riihela M, Seppala K: Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol 45:319-323, 1992
7. 7. Graham D: Pathogenic mechanisms leading to Helicobacter pylori-induced inflammation. Eur J Gastroenterol Hepatol 4(suppl 2):S9-S16, 1992
8. 8. Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, Sitas F: Association between infection with H. pylori and risk of gastric cancer. Evidence from a prospective investigation. BMJ 302:1302-1305, 1991
9. 9. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: H. pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127-1135, 1991
10. 10. Nomura A, Stemmerman GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ: H. pylori and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-1136, 1991
11. 11. Talley NJ, Zinsmeister AR, Weaver A, Dimagno EP, Carpenter HA, Perez-Perez GI, Blaser MJ: Gastric adenocarcinoma and H. pylori infection. J Natl Cancer Inst 83:1734-1739, 1991
12. 12. The Eurogast Study Group. An association between Helicobacter pylori infection and gastric cancer: An international study. Lancet 341:1359-1362, 1993
13. 13. Hansson LE, Engstrand L, Nyren O, Evans DJ, Lindren A, Betgstrom R, Andersson B, Athlin L, Bendtsen O, Tracz P: Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterology 105:1098-1103, 1993
14. 14. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. Evaluation of carcinogenic risks to humans. IARC Monograph Evaluating Carcinogenic Risks to Humans 61, 1994
15. 15. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ: Helicobacter pylori and atrophic gastritis: importance of CagA status. National Cancer Inst 87:1777-1780, 1995
16. 16. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmerman GN, Nomura A: Infection with Helicobacter pylori strains possessing cag A is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55:2111-2115, 1995
17. 17. Crabtree JE, Wyatt, Sobala GM, Miller G, Tompkins DS, Primrose JN, Morgan AG: Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 34:1339-1343, 1993
18. 18. Rokkas T, Liatsos C, Petridou E, Papatheodorou G, Karameris A: Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: The role of the CagA phenotype. Endoscopy 29:E36, 1997
19. 19. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Bodorovsky M, Rappuoli R, Covacci A: cagA a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 93:14648-14653, 1996
20. 20. Fraser AG, Sim R, Sankey EA, Dhillon AP, Pounder RE: Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther 8:167-173, 1994
21. 21. Lynch DA, Mapstone NP, Clarke AM, Sobala GM, Jackson P, Morrison L, Dixon MF, Quirke P, Axon AT: Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 36:346-350, 1995
22. 22. Harvard TJ, Sarsfield P, Wotherspoon AC, Steer HW: Increased gastric epithelial cell proliferation in Helicobacter pylori-associated follicular gastritis. J Clin Pathol 49:68-71, 1996
23. 23. Cahill RJ, O'Morain CA: Gastric epithelial cell proliferation. Eur J Cancer Prev 3:55-60, 1994
24. 24. Cahill RJ, Xia H, Kilgallen C, Beattie S, Hamilton H, O'Morain C: Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 40:1627-1631, 1995
25. 25. Bechi P, Balzi M, Beccioni A, Mangeni A, Raggi CC, Amorosi A, Dei R: Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis. Am J Gasroenterol 91:271-276, 1996
26. 26. Rokkas T, Liatsos C, Karameris A, Lazaris A, Antoniades D, Kalafatis E: Proliferating cell nuclear antigen (PCNA) immunostaining and nucleolar organiser regions (AgNORs) staining in Helicobacter pylori infection: Impact of eradication. Gastroenterology 112(suppl):A645, 1997
27. 27. Moss SF, Calam J, Agarwal B, Wang S, Holt PR: Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 38:498-501, 1996
28. 28. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ET, Mera R, Miller MJ, Correa P: Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: Effect of antibiotics and antioxidants. Cancer Res 56:3238-3243, 1996
29. 29. Slomiany BL, Piotrowsky J, Slomiany A: Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethasin: effect of omeprazole and ebriditine. Scand J Gastroenterol 32:638-642, 1997
30. 30. Marshall BJ, Francis G, Langton S, Goodwin CS, Blincow ED: Rapid urease test in the management of Campylobacter pyloridis associated gastritis. Am J Gastroenterol 3:200-210, 1987
31. 31. Potters HVPJ, Loffeld RJLF, Stobbering E, Van Spreeuwel JP, Arends JW: Rapid staining of Campylobacter pyloridis. Histopathology 11:1223, 1987
32. 33. Ploton D, Menager M, Jeannesson P, Himber G, Pigeon F, Adnett JJ: Improvement in the staining and the visualization of argyrophilic proteins of the nueleolar organizer region at the optimal level. Histochem J 18:5-14, 1986
33. 34. Correa P, Ruiz B, Shi TY, Janney A, Sobhan M, Torrado J, Hunter F: Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am J Clin Pathol 101:656-660, 1994
34. 35. Rosl F: A rapid and simple method for detection of apoptosis in human cells. Nucleic Acids 20:5243, 1992
35. 36. Schmitz GG, Walker T, Reibl R, Kessler C: Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem 192:222-231, 1991
36. 37. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, Covacci A: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessery for expression of the vacuolating cytotoxin. Infect Immun 63:94-98, 1995
37. 38. Motalsky H: Intuitive Biostatistics. Oxford University Press, New York, 1995
38. 39. Wagner S, Beil W, Westermann J, Logan RPH, Bock CT, Trautwein C, Bleck JC, Manns MP: Regulation of gastric epithelial cell growth by Helicobacter pylori: Evidence for a major role of apoptosis. Gastroenterology 113:1836-1844, 1997
39. 40. Peek RM Jr, Moss SF, Tham KT, Perez-Perez GI, Wang S, Miller GGM, Atherton JC, Holt PR, Blaser MJ: Helicobacter pylori cagA' strains and dissosiasion of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 89:863-868, 1997
40. 41. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardello FM, Zehnbauer BA, Hamilton SR, Jones RJ: Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55:1811-1816, 1995
41. 42. Moss SF, Scholes JV, Holt PR: Abnormalities of epithelial apoptosis in multistep colorectal neoplasia demonstrated by terminal deoxyuridine nick end labeling. Dig Dis Sci 41:2238-2247, 1996
42. 43. Chow KW, Bank S, Ahn J, Roberts J, Blumstein M, Kranz V: Helicobacter pylori infection does not increase gastric antrum mucosal cell proliferation. Am J Gastroenterol 90:64-66, 1995
43. 44. Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM: Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 151:1695-1703, 1997
44. 45. Sharma SA, Tummuru MK, Blaser MJ, Kerr LD: Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor muclear factor-kappa B in gastric epithelial cells. J Immunol 160:2401-2407, 1998
45. 46. Munzenmaier A, Lange C, Glocker E, Covacci A, Morran A, Bereswill S, Baeuerle PA, Kist M, Pahl HL: A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol 159:6140-6147, 1997
46. 47. Keates S, Hitti YS, Upton M, Kelly CP: Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology 113:1099-1109, 1997
47. 48. Crabtree JE, Wyatt J, Perry GR, Davies A, Covacci A, Morgan AG: CagA seropositive Helicobacter pylori infected non-ulcer patients have increased incidence of intestinal metaplasia. Gut 38(suppl 1):A3, 1996
48. 49. Scotiniotis IA, Rokkas T, Furth EE, Plotkin JW, Rigas B, Schiff SJ: Reduced apoptosis in H. pylori-associated gastric intestinal metaplasia: A factor in gastric carcinogenesis? Gastroenterology 114(No. 4): A676, 1998
49. 50. Vindigni C, Miracco C, Spina D, Presenti L, Gallonni M, Vatti R, de Stefano A, Roviello F, Pinto E, Filipe MI, Tosi P: Cell proliferation, cell death and angiogenesis in early and advanced gastric cancer of intestinal type. Int J Cancer 74:637-641, 1997
50. 51. Rokkas T, Filipe MI, Sladen GE: Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. Gut 32:1110-1113, 1991
51. 52. Cover TL, Glupczynski Y, Lage AP, Burette A, Tammuru MK, Perez-Perez GI, Blaser MJ: Serologic detection of infection with cagA (+) Helicobacter pylori strains. J Clin Microbiol 33:1496-1500, 1995
52. 53. Beales IL, Crabtree JE, Scunes D, Covacci A, Calam J: Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol 8:645-649, 1996
53. 54. Sozzi M, Valentini M, Figura N, De Paoli P, Tedeschi RM, Gloghini A, Serraino D, Poletti M, Carbone A: Atrophic gastritis and Intestinal metaplasia in Helicobacter pylori infection: The role of CagA status. Am J Gastroenterol 93:375-379, 1998
54. 55. Xiang Z, Bugnoli M, Ponzetto A, Mergando A, Figura N, Covacci A, Petracca R, Pennatini C, Cencini S, Armellini D: Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 12:739-745, 1993